| Dernellis et al.77 . | ACEI ± diuretic vs. controls . | Decrease in LA reservoir volume (35.4–29.3 mL); increase in LA conduit volume (43.8–51.3 mL) . |
|---|---|---|
| Mattioli et al.78 | Telmisartan at baseline and 1 year | Decrease in maximum LA volume (35 ± 5–32 ± 5 mL) |
| Tsang et al.79 | ACEI vs. placebo | Reduction in LAVI by 9.7 mL/m2 |
| Dernellis et al.77 . | ACEI ± diuretic vs. controls . | Decrease in LA reservoir volume (35.4–29.3 mL); increase in LA conduit volume (43.8–51.3 mL) . |
|---|---|---|
| Mattioli et al.78 | Telmisartan at baseline and 1 year | Decrease in maximum LA volume (35 ± 5–32 ± 5 mL) |
| Tsang et al.79 | ACEI vs. placebo | Reduction in LAVI by 9.7 mL/m2 |
CMR, cardiovascular magnetic resonance; LA, left atrium; LAVI, LA volume index.
| Dernellis et al.77 . | ACEI ± diuretic vs. controls . | Decrease in LA reservoir volume (35.4–29.3 mL); increase in LA conduit volume (43.8–51.3 mL) . |
|---|---|---|
| Mattioli et al.78 | Telmisartan at baseline and 1 year | Decrease in maximum LA volume (35 ± 5–32 ± 5 mL) |
| Tsang et al.79 | ACEI vs. placebo | Reduction in LAVI by 9.7 mL/m2 |
| Dernellis et al.77 . | ACEI ± diuretic vs. controls . | Decrease in LA reservoir volume (35.4–29.3 mL); increase in LA conduit volume (43.8–51.3 mL) . |
|---|---|---|
| Mattioli et al.78 | Telmisartan at baseline and 1 year | Decrease in maximum LA volume (35 ± 5–32 ± 5 mL) |
| Tsang et al.79 | ACEI vs. placebo | Reduction in LAVI by 9.7 mL/m2 |
CMR, cardiovascular magnetic resonance; LA, left atrium; LAVI, LA volume index.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
